256 related articles for article (PubMed ID: 24946870)
21. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
[TBL] [Abstract][Full Text] [Related]
22. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.
Qian X; Balestra ME; Yamanaka S; Borén J; Lee I; Innerarity TL
Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1013-20. PubMed ID: 9633945
[TBL] [Abstract][Full Text] [Related]
23. Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec1 and related nucleoside/nucleotide deaminases.
Nakamuta M; Oka K; Krushkal J; Kobayashi K; Yamamoto M; Li WH; Chan L
J Biol Chem; 1995 Jun; 270(22):13042-56. PubMed ID: 7768898
[TBL] [Abstract][Full Text] [Related]
24. Identification of novel alternative splice variants of APOBEC-1 complementation factor with different capacities to support apolipoprotein B mRNA editing.
Sowden MP; Lehmann DM; Lin X; Smith CO; Smith HC
J Biol Chem; 2004 Jan; 279(1):197-206. PubMed ID: 14570923
[TBL] [Abstract][Full Text] [Related]
25. Decreased expression of cholesterol 7alpha-hydroxylase and altered bile acid metabolism in Apobec-1-/- mice lead to increased gallstone susceptibility.
Xie Y; Blanc V; Kerr TA; Kennedy S; Luo J; Newberry EP; Davidson NO
J Biol Chem; 2009 Jun; 284(25):16860-16871. PubMed ID: 19386592
[TBL] [Abstract][Full Text] [Related]
26. C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.
Mukhopadhyay D; Anant S; Lee RM; Kennedy S; Viskochil D; Davidson NO
Am J Hum Genet; 2002 Jan; 70(1):38-50. PubMed ID: 11727199
[TBL] [Abstract][Full Text] [Related]
27. Involvement of a chaperone regulator, Bcl2-associated athanogene-4, in apolipoprotein B mRNA editing.
Lau PP; Chan L
J Biol Chem; 2003 Dec; 278(52):52988-96. PubMed ID: 14559896
[TBL] [Abstract][Full Text] [Related]
28. Thyroid hormone regulates hepatic triglyceride mobilization and apolipoprotein B messenger ribonucleic Acid editing in a murine model of congenital hypothyroidism.
Mukhopadhyay D; Plateroti M; Anant S; Nassir F; Samarut J; Davidson NO
Endocrinology; 2003 Feb; 144(2):711-9. PubMed ID: 12538634
[TBL] [Abstract][Full Text] [Related]
29. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity.
Siddiqui JF; Van Mater D; Sowden MP; Smith HC
Exp Cell Res; 1999 Oct; 252(1):154-64. PubMed ID: 10502408
[TBL] [Abstract][Full Text] [Related]
30. Intracellular trafficking determinants in APOBEC-1, the catalytic subunit for cytidine to uridine editing of apolipoprotein B mRNA.
Yang Y; Sowden MP; Yang Y; Smith HC
Exp Cell Res; 2001 Jul; 267(2):153-64. PubMed ID: 11426934
[TBL] [Abstract][Full Text] [Related]
31. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.
Mehta A; Kinter MT; Sherman NE; Driscoll DM
Mol Cell Biol; 2000 Mar; 20(5):1846-54. PubMed ID: 10669759
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein B RNA sequence 3' of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing.
Sowden MP; Eagleton MJ; Smith HC
Nucleic Acids Res; 1998 Apr; 26(7):1644-52. PubMed ID: 9512534
[TBL] [Abstract][Full Text] [Related]
33. APOBEC-1-mediated RNA editing.
Blanc V; Davidson NO
Wiley Interdiscip Rev Syst Biol Med; 2010; 2(5):594-602. PubMed ID: 20836050
[TBL] [Abstract][Full Text] [Related]
34. Apobec-1 and apolipoprotein B mRNA editing.
Chan L; Chang BH; Nakamuta M; Li WH; Smith LC
Biochim Biophys Acta; 1997 Mar; 1345(1):11-26. PubMed ID: 9084497
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism.
Morrison JR; Pászty C; Stevens ME; Hughes SD; Forte T; Scott J; Rubin EM
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7154-9. PubMed ID: 8692961
[TBL] [Abstract][Full Text] [Related]
36. APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family.
Liao W; Hong SH; Chan BH; Rudolph FB; Clark SC; Chan L
Biochem Biophys Res Commun; 1999 Jul; 260(2):398-404. PubMed ID: 10403781
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals.
Yamanaka S; Balestra ME; Ferrell LD; Fan J; Arnold KS; Taylor S; Taylor JM; Innerarity TL
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8483-7. PubMed ID: 7667315
[TBL] [Abstract][Full Text] [Related]
38. The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors.
Sowden MP; Ballatori N; Jensen KL; Reed LH; Smith HC
J Cell Sci; 2002 Mar; 115(Pt 5):1027-39. PubMed ID: 11870221
[TBL] [Abstract][Full Text] [Related]
39. Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits.
Greeve J; Jona VK; Chowdhury NR; Horwitz MS; Chowdhury JR
J Lipid Res; 1996 Sep; 37(9):2001-17. PubMed ID: 8895066
[TBL] [Abstract][Full Text] [Related]
40. Effects of apo E deficiency on plasma lipid levels in mice lacking APOBEC-1.
Osuga J; Yagyu H; Ohashi K; Harada K; Yazaki Y; Yamada N; Ishibashi S
Biochem Biophys Res Commun; 1997 Jul; 236(2):375-8. PubMed ID: 9240444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
